ClinVar Genomic variation as it relates to human health
NM_018723.4(RBFOX1):c.724A>G (p.Ser242Gly)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_018723.4(RBFOX1):c.724A>G (p.Ser242Gly)
Variation ID: 2909229 Accession: VCV002909229.1
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 16p13.3 16: 7630650 (GRCh38) [ NCBI UCSC ] 16: 7680652 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Feb 20, 2024 Feb 20, 2024 Aug 27, 2023 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_018723.4:c.724A>G MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_061193.2:p.Ser242Gly missense NM_145893.3:c.784A>G MANE Plus Clinical Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_665900.1:p.Ser262Gly missense NM_001142333.2:c.677-23165A>G intron variant NM_001142334.2:c.724A>G NP_001135806.1:p.Ser242Gly missense NM_001308117.1:c.853A>G NP_001295046.1:p.Ser285Gly missense NM_001364800.2:c.724A>G NP_001351729.1:p.Ser242Gly missense NM_001411047.1:c.853A>G NP_001397976.1:p.Ser285Gly missense NM_001415887.1:c.1321A>G NP_001402816.1:p.Ser441Gly missense NM_001415888.1:c.1274-23165A>G intron variant NM_001415889.1:c.832A>G NP_001402818.1:p.Ser278Gly missense NM_001415890.1:c.799A>G NP_001402819.1:p.Ser267Gly missense NM_001415891.1:c.853A>G NP_001402820.1:p.Ser285Gly missense NM_001415892.1:c.832A>G NP_001402821.1:p.Ser278Gly missense NM_001415893.1:c.799A>G NP_001402822.1:p.Ser267Gly missense NM_001415894.1:c.832A>G NP_001402823.1:p.Ser278Gly missense NM_001415895.1:c.853A>G NP_001402824.1:p.Ser285Gly missense NM_001415896.1:c.784A>G NP_001402825.1:p.Ser262Gly missense NM_001415897.1:c.806-23165A>G intron variant NM_001415898.1:c.832A>G NP_001402827.1:p.Ser278Gly missense NM_001415899.1:c.799A>G NP_001402828.1:p.Ser267Gly missense NM_001415900.1:c.785-23165A>G intron variant NM_001415901.1:c.799A>G NP_001402830.1:p.Ser267Gly missense NM_001415902.1:c.730A>G NP_001402831.1:p.Ser244Gly missense NM_001415903.1:c.752-23165A>G intron variant NM_001415904.1:c.784A>G NP_001402833.1:p.Ser262Gly missense NM_001415905.1:c.706A>G NP_001402834.1:p.Ser236Gly missense NM_001415906.1:c.737-23165A>G intron variant NM_001415907.1:c.806-23165A>G intron variant NM_001415908.1:c.760A>G NP_001402837.1:p.Ser254Gly missense NM_001415909.1:c.785-23165A>G intron variant NM_001415910.1:c.739A>G NP_001402839.1:p.Ser247Gly missense NM_001415911.1:c.730A>G NP_001402840.1:p.Ser244Gly missense NM_001415912.1:c.692-23165A>G intron variant NM_001415913.1:c.752-23165A>G intron variant NM_001415914.1:c.713-23165A>G intron variant NM_001415915.1:c.737-23165A>G intron variant NM_001415916.1:c.631A>G NP_001402845.1:p.Ser211Gly missense NM_001415917.1:c.683-23165A>G intron variant NM_145891.3:c.784A>G NP_665898.1:p.Ser262Gly missense NM_145892.3:c.784A>G NP_665899.1:p.Ser262Gly missense NC_000016.10:g.7630650A>G NC_000016.9:g.7680652A>G NG_011881.2:g.2395899A>G - Protein change
- S236G, S267G, S278G, S211G, S242G, S244G, S262G, S254G, S247G, S285G, S441G
- Other names
- -
- Canonical SPDI
- NC_000016.10:7630649:A:G
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
RBFOX1 | Little evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh37 |
542 | 694 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Uncertain significance (1) |
criteria provided, single submitter
|
Aug 27, 2023 | RCV003639178.2 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Uncertain significance
(Aug 27, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Idiopathic generalized epilepsy
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV004537887.1
First in ClinVar: Feb 20, 2024 Last updated: Feb 20, 2024 |
Comment:
This sequence change replaces serine, which is neutral and polar, with glycine, which is neutral and non-polar, at codon 262 of the RBFOX1 protein (p.Ser262Gly). … (more)
This sequence change replaces serine, which is neutral and polar, with glycine, which is neutral and non-polar, at codon 262 of the RBFOX1 protein (p.Ser262Gly). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with RBFOX1-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt RBFOX1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpThere are no citations for germline classification of this variant in ClinVar. If you know of citations for this variation, please consider submitting that information to ClinVar. |
Text-mined citations for this variant ...
HelpRecord last updated Sep 30, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.